Volume 12 (2014): Issue 4 (Apr 2014)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xxi–xxxiii
Oncology Research Program
Pages: xxxvi
The Changing Face of Community Practice: The New Normal
By: Margaret Tempero
Pages: 449
Correspondence
By: Thein Hlaing Oo
Pages: 451–452
Correspondence
By: Alok A. Khorana
Pages: 452–453
Part 2: Abstracts from the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™
Pages: 455–462
Multiple Successful Desensitizations to Brentuximab Vedotin: A Case Report and Literature Review
By: Michael D. DeVita, Andrew M. Evens, Steven T. Rosen, Paul A. Greenberger, and Adam M. Petrich
Pages: 465–471
Soft Tissue Sarcoma, Version 2.2014
By: Margaret von Mehren, R. Lor Randall, Robert S. Benjamin, Sarah Boles, Marilyn M. Bui, Ephraim S. Casper, Ernest U. Conrad III, Thomas F. DeLaney, Kristen N. Ganjoo, Suzanne George, Ricardo J. Gonzalez, Martin J. Heslin, John M. Kane III, Joel Mayerson, Sean V. McGarry, Christian Meyer, Richard J. O’Donnell, Alberto S. Pappo, I. Benjamin Paz, John D. Pfeifer, Richard F. Riedel, Scott Schuetze, Karen D. Schupak, Herbert S. Schwartz, Brian A. Van Tine, Jeffrey D. Wayne, Mary Anne Bergman, and Hema Sundar
Pages: 473–483
Survivorship: Pain Version 1.2014
By: Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole McMillian, and Deborah Freedman-Cass
Pages: 488–500
Advances in Supportive Care for Multiple Myeloma
By: Noopur S. Raje, Andrew J. Yee, and G. David Roodman
Pages: 502–511
Neoadjuvant Chemotherapy First, Followed by Chemoradiation and Then Surgery, in the Management of Locally Advanced Rectal Cancer
By: Andrea Cercek, Karyn A. Goodman, Carla Hajj, Emily Weisberger, Neil H. Segal, Diane L. Reidy-Lagunes, Zsofia K. Stadler, Abraham J. Wu, Martin R. Weiser, Philip B. Paty, Jose G. Guillem, Garrett M. Nash, Larissa K. Temple, Julio Garcia-Aguilar, and Leonard B. Saltz
Pages: 513–519
Management of Patients With Cytogenetically Normal Acute Myeloid Leukemia Who Have Neither Favorable nor Unfavorable Markers
By: Alison R. Walker and Guido Marcucci
Pages: 527–534
Breast Cancer Version 3.2014
By: William J. Gradishar, Benjamin O. Anderson, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Lori J. Goldstein, Daniel F. Hayes, Clifford A. Hudis, Steven J. Isakoff, Britt-Marie E. Ljung, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Robert S. Miller, Mark Pegram, Lori J. Pierce, Elizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Mary Lou Smith, Hatem Soliman, George Somlo, John H. Ward, Antonio C. Wolff, Richard Zellars, Dorothy A. Shead, and Rashmi Kumar
Pages: 542–590
Pertuzumab in the Treatment of HER2+ Breast Cancer
By: Komal Jhaveri and Francisco J. Esteva
Pages: 591–598
Renaming Ductal Carcinoma in Situ: Would Removing “Carcinoma” Reduce Overtreatment?
By: Sara H. Javid, L. Christine Fang, Larissa Korde, and Benjamin O. Anderson
Pages: 599–602
  • Collapse
  • Expand